Feb. 13, 2018—Inspirata, a biotechnology and software company, announced it has acquired Pittsburgh-based Omnyx from GE Healthcare. Omnyx’s flagship digital pathology software, Dynamyx, aims to enhance the pathology workflow by providing new channels for collaboration and tools to boost efficiency. The software is CE-marked in Europe and licensed by Health Canada for in vitro diagnostic use.
“The acquisition of Omnyx positions Inspirata with the most comprehensive digital pathology workflow solution in the world,” Satish Sanan, CEO of Inspirata, said in a statement. “It brings us the last mile to reach our goal of having an end-to-end integrated pathology solution with a scanner-agnostic whole slide image viewer and image management system. It also gives us a fully supported IVD device cleared for primary digital diagnosis in Europe and Canada, and it expands our customer base and geographic footprint across those countries.”
Inspirata intends to leverage Omnyx’s decade of experience in the field to create a center of excellence for ongoing digital pathology software development. The companies will converge Dynamyx with Inspirata’s Digital Pathology Cockpit to bring an enhanced, scanner-agnostic digital pathology platform to market. Omnyx will retain its brand and its employees in Pittsburgh.